Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?

doi:10.3748/wjg.v18.i29.3839

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10614)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

911

HTML

9493

Figures (1-1)

210

Sum=10614

Aug 7, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (155)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 7, 2012; 18(29): 3839-3848
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3839

Full Size Figure Download Figure

Figure 1 Surveillance recommendations for patients with colitis. OR: Odds ratio; CRC: Colorectal cancer; PSC: Primary sclerosing cholangitis; FDR: First degree relative.

Citation: Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk? World J Gastroenterol 2012; 18(29): 3839-3848
URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3839.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i29.3839